TGA
Potential COVID-19 drug poses retinal toxicity risk
The Australian Therapeutic Goods Administration (TGA) has warned that an autoimmune and malaria drug being investigated as a potential treatment ...
New dry eye therapy now TGA-approved
Australian drug regulators have approved a new aqueous, immunosuppressant for the treatment of moderate-to-severe dry eye. Cequa (ciclosporin 900 microgram/mL) ...
Novartis secures approval for AMD drug in Australia
Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the ...